Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2026-08-11 16:15:03 ET · period of report 2026-08-06 · accession 0001193125-26-344682 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-11 16:15 | 2026-08-06 | TCRT | Weis Holger | CEO | A - Grant | $2.01 | +4,363 | 25.5K | +21% | +$8,770 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-06 | A | A | 4,363 | $2.01 | 25,483 | D | — | — | (F1) Represents shares of common stock issued in lieu of net salary. |